TickerGuard
Buy Day today: Poor (52) Mixed market breadth · today: Core PCE (August) ≈
ANNX

Annexon Inc

Healthcare · Biotechnology

3.80$ -1.8% vs. previous close Closing price · As of: Sep 24, 2026

Statements

Balance Sheet

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Balance Sheet ANNX
Line item 2017 2018 2019 2020 2021 2022 2023 2024 2025
– +515.6% +3.6% +613.3% -19.4% -0.7% +4.4% +17.6% -20.7%
– +834.1% -0.7% +679.7% -30.0% +0.2% +6.4% +19.9% -23.5%
– +1,389.4% -0.6% +511.3% -72.1% +87.1% +60.8% -78.0% +227.4%
– +1,389.4% -0.6% +699.4% -30.9% 0.0% +7.0% +20.1% -23.6%
– -61.3% -64.9% -96.2% – – – – –
– – – – – – – – –
– -16.7% -8.8% -9.5% +1,873.2% -55.9% – – –
– -81.0% -38.0% +83.2% +372.5% -2.2% -12.6% +20.9% +15.7%
– +14.1% +48.3% +115.4% +104.7% +2.8% -19.8% +70.2% +39.7%
– – – – +207.4% +9.5% +64.5% +16.3% +15.5%
– -16.6% +86.5% +57.5% +198.7% -33.5% -26.0% +90.0% +43.2%
– – +14.9% +690.9% -32.6% -0.3% +8.4% +17.0% -27.8%
– – – – – – – – –
– -70.0% +233.7% -55.6% +125.9% +42.7% +38.4% +81.6% +12.9%

Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?